HEALTH MEDIA NOW-GERALD VARDZEL-TRENDS IN PERSONALIZED MEDICINE

Please join us Wednesday, July 18, 2018 at 4:00 p.m. PST and 7:00 p.m. EST for a live show with host Denise Messenger. Gerald Vardzel, President and CEO of Helomics will be joining us for an informative and lively interview regarding the trends in personalized medicine and how their company can help in a cancer diagnosis. Mr. Vardzel has over 25 years of healthcare executive management experience developing and implementing commercialization strategies and models for technology launches.  He has developed innovative solutions for both CLIA and FDA regulatory paths defining the delivery chains from discovery to clinical acceptance. Mr. Vardzel was previously Vice President of Corporate Development and Strategic Initiatives at Global Specimen Solutions.  Mr. Vardzel graduated from the University of Pittsburgh. Helomics’ services are tailored to the specific requirements of our clients within the pharmaceutical, diagnostic, biotechnology and academic industries. Projects are performed on a fee-for-service basis according to a project proposal that specifies a detailed scope of work, timeline, and budget. We bring a unique combination of live and fixed cell bioanalytical capabilities, backed by extensive expertise, to help you achieve your project goals.